How the Oral Glucose Tolerance Test (OGTT) is Performed in Pregnancy
The OGTT in pregnancy is performed at 24-28 weeks of gestation using either a one-step approach (75g glucose load with measurements at fasting, 1-hour, and 2-hour) or a two-step approach (initial 50g screening test followed by 100g diagnostic test if positive), with specific patient preparation and timing requirements that must be strictly followed. 1, 2
Patient Preparation Requirements
Before performing the OGTT, ensure the following conditions are met:
- The test must be done in the morning after an overnight fast of 8-14 hours 1
- The patient should consume at least 150g of carbohydrate per day for at least 3 days before the test 1
- Unlimited physical activity should be maintained in the days leading up to the test 1
- The patient must remain seated throughout the entire test and should not smoke 1
One-Step Approach (IADPSG Criteria)
This approach uses a 75g glucose load with three measurement time points 1, 2:
Measurement Schedule:
Diagnostic Thresholds (any single value meeting or exceeding these indicates GDM):
This approach identifies approximately 15-20% of pregnant women with GDM, which is 2-3 times more cases than the two-step approach. 2
Two-Step Approach (ACOG-Supported)
Step 1: Initial Screening (50g Glucose Challenge Test)
- Performed at 24-28 weeks of gestation 1, 2
- Does not require fasting 1, 2
- Single blood draw at 1 hour after 50g glucose load 1
- Proceed to Step 2 if glucose ≥140 mg/dL (some use ≥130 mg/dL threshold) 1
Step 2: Diagnostic Test (100g OGTT)
Performed only if Step 1 is positive, requires fasting 1
Measurement Schedule:
- Fasting (baseline)
- 1 hour after 100g glucose administration
- 2 hours after glucose administration
- 3 hours after glucose administration 1
Diagnostic Thresholds (Carpenter/Coustan criteria - at least 2 of 4 values must meet or exceed):
- Fasting: ≥95 mg/dL (5.3 mmol/L)
- 1-hour: ≥180 mg/dL (10.0 mmol/L)
- 2-hour: ≥155 mg/dL (8.6 mmol/L)
- 3-hour: ≥140 mg/dL (7.8 mmol/L) 1, 2
This approach identifies approximately 5-6% of pregnant women with GDM. 2
Special Circumstances: High-Risk Women
Women with marked obesity (BMI ≥30 kg/m²), personal history of GDM, glycosuria, or strong family history of diabetes should undergo glucose testing as early as the first prenatal visit (12-14 weeks). 1, 3
- If negative at first prenatal visit, these high-risk women must be retested at 24-28 weeks of gestation 1, 3
- Early testing uses the same OGTT protocols but aims to detect pre-existing undiagnosed type 2 diabetes 3
Important Clinical Caveats
The analytical reliability of the OGTT has limitations - research shows that with the maximum allowable analytical error of 6.9% for glucose measurements, GDM prevalence could theoretically vary from 4.5% to 25.3% depending on measurement variability, compared to the standard 12.2% prevalence. 4 This underscores the importance of proper laboratory technique and quality control.
ACOG currently supports the two-step approach but notes that a single elevated value can be used for GDM diagnosis, representing an evolution in diagnostic thinking. 2
The choice between one-step and two-step approaches remains controversial and depends on factors including GDM prevalence in your population, available resources, and cost-effectiveness considerations. 2 The one-step approach may be more cost-effective in high-risk populations. 1